Pharma company Dr Reddy's Laboratories has raised Rs 1,077 crore debt in the current quarter to meet working capital requirements and also refinancing old loans. In a filing to the Securities Exchange Commission, Dr Reddy's informed that one of the Company’s subsidiaries in Switzerland entered into a loan agreement with a consortium of International banks to borrow the sum of Rs 1,077.50 crore ($220 million). On October 20, 2011, the company, through its Swiss Subsidiary, drew down an amount of Rs 1,077.50 crore ($220 million) under its loan agreement dated September 28, 2011 with Citigroup Global Markets Asia Limited and the other Swiss Subsidiary Lenders. The term of the loan is for sixty months starting from September 30, 2011.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1668.00 |
| Dr. Reddys Lab | 1232.25 |
| Cipla | 1228.90 |
| Zydus Lifesciences | 936.35 |
| Lupin | 2328.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: